Cargando…
Severe pediatric asthma with a poor response to omalizumab: a report of three cases and three-dimensional bronchial wall analysis
Omalizumab is used for the treatment of persistent severe allergic asthma in adults and children. However, some patients remain symptomatic even after omalizumab treatment. In bronchial asthma, chronic inflammation of the bronchial wall causes thickening of the airway wall, resulting from irreversib...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743945/ https://www.ncbi.nlm.nih.gov/pubmed/34994237 http://dx.doi.org/10.1177/03000605211070492 |